AG
KDNY

Advisor Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Advisor Group’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
136
– – ﹤0.01% 5235
2019
Q3 		$1K Buy
+136
New +$903 ﹤0.01% 5199
2018
Q2 		– Sell
-8
Closed – – 5084
2018
Q1 		$0 Hold
8
– – ﹤0.01% 5101
2017
Q4 		$0 Hold
8
– – ﹤0.01% 5098
2017
Q3 		$0 Buy
+8
New +$475 ﹤0.01% 4985
2016
Q3 		– Sell
-8
Closed – – 4655
2016
Q2 		$0 Buy
+8
New +$486 ﹤0.01% 4541

Other funds holding KDNY

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Group's KDNY Position: Q4 2019 in Review

Advisor Group held its Chinook Therapeutics, Inc. Common Stock (KDNY) position steady in Q4 2019 at 136 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5235.

Advisor Group first reported a position in KDNY in Q2 2016 and has held it in 6 quarters since. 84 funds tracked by Wall St. Rank hold KDNY as of Q4 2019.

  • Advisor Group held 136 shares of Chinook Therapeutics, Inc. Common Stock worth $1K as of Q4 2019.
  • Advisor Group left its Chinook Therapeutics, Inc. Common Stock share count unchanged in Q4 2019.
  • Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5235 holding.
  • Advisor Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and has held it in 6 quarters since.
  • 84 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.